The role of transrectal ultrasonography on the palpable and impalpable abnormal prostate

T. S. Tzai, J. S.N. Lin, I. C. Yeh, N. H. Chow

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Two hundred and three male patients underwent transrectal ultrasonography (TRUS) examination because of palpable nodule or hard consistency of the prostate. Of these, 56 of 65 (86.2%) digital rectal examination (DRE)-abnormal and 34 of 138 (24.6%) DRE-normal patients received transrectal sono-guided core needle biopsy. Among the DRE-abnormal patients, 18 (32.1%) had prostatic adenocarcinoma by biopsy with 2 additional patients who had initial negative biopsies eventually found to have cancer by transurethral resection of the prostate. In contrast, only 2 (5.9%) of 34 DRE-normal patients had cancers that were both hypoechoic and peripheral zone located. In 13 patients with transitional zone located lesions (hypacchoic 9, isoechoic 4), none had cancer, Of 27 patients who had normal DRE and unsuspected TRUS and received transurethral prostatectomy because of bladder outlet obstruction, 4 (14.8%) had cancer. In this study, hypoechoic lesions were found in 68 patients, among them 60 (88.2%) underwent biopsy but only 14 (23.3%) had cancer. From the results of this study, we concluded that TRUS can be a useful adjunct of DRE in detecting prostatic malignancy, especially when there has been an abnormal DRE, but its role on a digitally normal prostate requires further evaluation, Serum prostate-specific antigen can be an additional indicator to increase the prostate cancer detection rate.

Original languageEnglish
Pages (from-to)142-145
Number of pages4
JournalEuropean Urology
Issue number2
Publication statusPublished - 1995 Jan 1

All Science Journal Classification (ASJC) codes

  • Urology


Dive into the research topics of 'The role of transrectal ultrasonography on the palpable and impalpable abnormal prostate'. Together they form a unique fingerprint.

Cite this